| Net Cash Provided by (Used in) Operating Activities |
$5,395,000 |
USD |
56% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$2,993,000 |
USD |
-14% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$4,082,000 |
USD |
-17% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
75,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
43,803,243 |
shares |
0.09% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$12,470,000 |
USD |
32% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$22,385 |
USD |
|
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$41,076,000 |
USD |
19% |
Q4 2024 |
FY 2024 |
| Depreciation |
$2,328,000 |
USD |
-11% |
Q1 2025 |
Q1 2025 |
| Payments to Acquire Property, Plant, and Equipment |
$4,003,000 |
USD |
76% |
Q1 2025 |
Q1 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$15,503,000 |
USD |
-59% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability, Current |
$0 |
USD |
-100% |
Q4 2024 |
FY 2024 |
| Deferred Income Tax Expense (Benefit) |
$0 |
USD |
-100% |
Q1 2025 |
Q1 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
5,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$206,124,000 |
USD |
0.59% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$18,691,000 |
USD |
-8% |
Q4 2024 |
FY 2024 |
| Interest Expense |
$140,000 |
USD |
8.5% |
Q1 2024 |
Q1 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |